Request Deal Involvement

Grünenthal completed the acquisition of Nebido from Bayer for €500m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

UBS

financial advisors

UBS

Allen & Overy

legal advisors

Allen & Overy

Freshfields Bruckhaus Deringer

legal advisors

Freshfields Bruckhaus Deringer

BNP Paribas

financial advisors

BNP Paribas

or

Principals

BAYER AG

vendor

BAYER AG

GRUNENTHAL

bidder

GRUNENTHAL

BAYER (NEBIDO PRODUCT)

target

BAYER (NEBIDO PRODUCT)

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Grünenthal completed the acquisition of Nebido from Bayer for €500m.